CLOSE

Saverio Minucci

  • Publications

    • THALER F, VARASI M, ABATE A, CARENZI G, COLOMBO A, BIGOGNO C, BOGGIO R, DAL ZUFFO R, RAPETTI D, RESCONI A, REGALIA N, VULTAGGIO S, DONDIO G, GAGLIARDI S, MINUCCI S, MERCURIO C (2013). Synthesis and biological characterization of spiro[2H-(1,3)-benzoxazine-2,4'-piperidine] based histone deacetylase inhibitors. European journal of medicinal chemistry 04/2013; 64C:273-284.
    • SANTORO F, BOTRUGNO OA, DAL ZUFFO R, PALLAVICINI I, MATTHEWS GM, CLUSE L, BAROZZI I, SENESE S, FORNASARI L, MORETTI S, ALTUCCI S, PELICCI PG, CHIOCCA S, JOHNSTONE RW, MINUCCI S (2013). A dual role for Hdac1: oncosuppressor in tumorigenesis, oncogene in tumor maintenance. Blood, 121 (17): 3459-68. doi:10.1182/blood-2012-10-461988
    • SONCINI M, SANTORO F, GUTIERREZ A, FRIGÈ G, ROMANENGHI M, BOTRUGNO OA, PALLAVICINI I, PELICCI P, DI CROCE L, MINUCCI S (2013). The DNA demethylating agent decitabine activates the TRAIL pathway and induces apoptosis in acute myeloid leukemia. BIOCHIMICA ET BIOPHYSICA ACTA, 1832 (1): 114-20. ISSN: 0006-3002
    • KLIONSKY DJ et al. (2012). Guidelines for the use and interpretation of assays for monitoring autophagy.Autophagy, 8: 4, 445-544, April 2012.
    • SAEED S, LOGIE C, FRANCOIJS KJ, FRIGÈ G, ROMANENGHI M, NIELSEN FG, RAATS L, SHAHHOSEINI M, HUYNEN M, ALTUCCI L, MINUCCI S, MARTENS JH, STUNNENBERG HG (2012). Chromatin accessibility, p300 and histone acetylation define PML-RARa and AML1-ETO binding sites in acute myeloid leukemia. BLOOD, vol. 120, p. 3058-3068, ISSN: 0006-4971

UN PICCOLO GESTO E' PER NOI UN GRANDE AIUTO

PARTNERSHIP

Università degli Studi di Milano Ecancer Medical Science IFOM-IEO Campus

CREDITS

Ministero della Salute Joint Commission International Breastcertification bollinirosa

© 2013 Istituto Europeo di Oncologia - via Ripamonti 435 Milano - P.I. 08691440153 - Codice intermediario fatturazione elettronica: A4707H7

IRCCS - ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO